| Literature, Linguistics and Cultural Studies | 2021-2025 | 359 | US 77 | 97.59 |
| Dermatology | Lifetime | 145 | US 60 | 99.04 |
| Pathology and Forensic Medicine | Lifetime | 594 | US 275 | 97.38 |
| Cultural Studies | Lifetime | 800 | US 379 | 96.36 |
| Rheumatology | Lifetime | 774 | US 356 | 96.02 |
| Urology | Lifetime | 635 | US 274 | 86.91 |
| Periodontics | Lifetime | 744 | US 219 | 74.70 |
| Cultural Studies | 2021-2025 | 29 | US 5 | 99.08 |
| Dermatology | 2021-2025 | 149 | US 47 | 95.10 |
| Pathology and Forensic Medicine | 2021-2025 | 353 | US 119 | 87.29 |
| Clinical Psychology | 2021-2025 | 996 | US 387 | 88.16 |
| Oncology | 2021-2025 | 939 | US 396 | 83.11 |
| Rheumatology | 2021-2025 | 398 | US 127 | 82.66 |
| Clinical Pharmacology | 2021-2025 | 399 | US 114 | 81.75 |
| Genetics | 2021-2025 | 702 | US 265 | 78.34 |
| Pharmacology | 2021-2025 | 135 | US 37 | 72.49 |
| Urology | 2021-2025 | 173 | US 54 | 67.46 |
| Cancer and Skin Lesions | Lifetime | 89 | US 49 | 98.92 |
| Genetic and rare skin diseases. | Lifetime | 32 | US 19 | 98.84 |
| Skin Diseases and Diabetes | Lifetime | 30 | US 16 | 98.72 |
| Cancer Diagnosis and Treatment | Lifetime | 268 | US 144 | 98.45 |
| Nail Diseases and Treatments | Lifetime | 125 | US 54 | 98.65 |
| Autoimmune and Inflammatory Disorders | Lifetime | 70 | US 28 | 98.71 |
| Tumors and Oncological Cases | Lifetime | 129 | US 85 | 98.52 |
| Chemotherapy-related skin toxicity | Lifetime | 42 | US 25 | 97.96 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 132 | US 56 | 98.35 |
| Vascular Malformations and Hemangiomas | Lifetime | 104 | US 63 | 97.74 |
| Autoimmune Bullous Skin Diseases | Lifetime | 214 | US 77 | 98.32 |
| Genital Health and Disease | Lifetime | 245 | US 117 | 97.70 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 222 | US 99 | 97.61 |
| Drug-Induced Adverse Reactions | Lifetime | 210 | US 63 | 96.86 |
| Dermatologic Treatments and Research | Lifetime | 340 | US 155 | 96.66 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 268 | US 100 | 96.21 |
| Vascular Tumors and Angiosarcomas | Lifetime | 318 | US 168 | 96.04 |
| Cutaneous Melanoma Detection and Management | Lifetime | 569 | US 261 | 96.27 |
| Dermatological and Skeletal Disorders | Lifetime | 251 | US 88 | 95.27 |
| Dermatological and COVID-19 studies | Lifetime | 135 | US 33 | 92.58 |
| Oral Health Pathology and Treatment | Lifetime | 647 | US 205 | 94.96 |
| Ear and Head Tumors | Lifetime | 563 | US 298 | 94.91 |
| Hair Growth and Disorders | Lifetime | 313 | US 118 | 94.16 |
| Soft tissue tumor case studies | Lifetime | 500 | US 256 | 93.79 |
| Soft tissue tumors and treatment | Lifetime | 99 | US 49 | 93.88 |
| Acne and Rosacea Treatments and Effects | Lifetime | 309 | US 136 | 94.08 |
| Dermatological diseases and infestations | Lifetime | 247 | US 116 | 93.19 |
| Eosinophilic Disorders and Syndromes | Lifetime | 959 | US 370 | 93.90 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 594 | US 208 | 92.98 |
| Urticaria and Related Conditions | Lifetime | 959 | US 273 | 93.37 |
| Hedgehog Signaling Pathway Studies | Lifetime | 742 | US 353 | 91.91 |
| Tattoo and Body Piercing Complications | Lifetime | 55 | US 29 | 91.57 |
| Body Image and Dysmorphia Studies | Lifetime | 419 | US 164 | 91.68 |
| Infectious Diseases and Mycology | Lifetime | 916 | US 340 | 90.94 |
| Dupuytren's Contracture and Treatments | Lifetime | 182 | US 79 | 89.40 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 35 | US 10 | 85.29 |
| Poxvirus research and outbreaks | Lifetime | 645 | US 292 | 89.78 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 282 | US 80 | 86.35 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 699 | US 161 | 83.94 |
| Medicine and Dermatology Studies History | Lifetime | 750 | US 276 | 82.61 |
| Bartonella species infections research | Lifetime | 586 | US 219 | 75.36 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 514 | US 189 | 72.78 |
| Actinomycetales infections and treatment | Lifetime | 887 | US 216 | 70.81 |
| Cancer and Skin Lesions | 2021-2025 | 29 | US 10 | 96.22 |
| Genital Health and Disease | 2021-2025 | 131 | US 45 | 92.18 |
| Genetic and rare skin diseases. | 2021-2025 | 35 | US 5 | 85.83 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 206 | US 60 | 91.38 |
| Tumors and Oncological Cases | 2021-2025 | 119 | US 48 | 87.89 |
| Chemotherapy-related skin toxicity | 2021-2025 | 73 | US 32 | 83.32 |
| Nail Diseases and Treatments | 2021-2025 | 313 | US 72 | 85.59 |
| Urticaria and Related Conditions | 2021-2025 | 400 | US 77 | 86.80 |
| Tattoo and Body Piercing Complications | 2021-2025 | 15 | US 4 | 85.47 |
| Drug-Induced Adverse Reactions | 2021-2025 | 301 | US 76 | 83.84 |
| Dermatologic Treatments and Research | 2021-2025 | 487 | US 112 | 83.76 |
| Body Image and Dysmorphia Studies | 2021-2025 | 198 | US 50 | 82.44 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 647 | US 117 | 82.58 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 881 | US 239 | 81.57 |
| Soft tissue tumor case studies | 2021-2025 | 200 | US 78 | 77.36 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 346 | US 103 | 76.64 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 352 | US 77 | 76.56 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 408 | US 129 | 66.85 |
| Dermatological and Skeletal Disorders | 2021-2025 | 712 | US 177 | 45.24 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 335 | US 87 | 22.39 |
